Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.

(RTTNews) - Citius Oncology, Inc. (CTOR), the oncology subsidiary of Citius Pharmaceuticals Inc. (CTXR) announced the U.S. commercial launch of LYMPHIR, a new immunotherapy for adults with relapsed or ...

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate of recurrence after surgery. Even after complete tumor removal, microscopic ...

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

Effective therapy is about more than insight or advice. It is about transformation—a felt shift in how we relate to ourselves and others in real time. Systemic therapy, grounded in family systems ...

Acne remains a very common inflammatory dermatosis, which is often associated with significant psychological morbidity. It frequently affects young adults at a time when they are undergoing maximal ...

In these turbulent times, families have suffered devastating losses of loved ones, from the anguish of COVID-related deaths to gun violence, drug overdose, suicide, environmental disasters, and war.